Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
John Rieth(University of Iowa Hospitals and Clinics), Mohammed Milhem(University of Iowa), Sarah L. Mott(University of Iowa), Marion Vanneste(University of Iowa), Yousef Zakharia(University of Iowa), Michael D. Henry(University of Iowa), Jeremy D.W. Greenlee(University of Iowa Hospitals and Clinics), Mario Zanaty, Brooke M. Jennings(University of Iowa), Aaron Bossler(University of Iowa), Umang Swami(University of Utah)
Cited by 12
Related Papers
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2021|411
Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration
|Cell|2002|297
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274